Publications by Asta Juzeniene

137 publications found

  1. Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE (2022)
    Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
    Int J Epidemiol (in press)
    DOI 10.1093/ije/dyac223, PubMed 36413027
  2. Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
    Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
    Cancers (Basel), 14 (11)
    DOI 10.3390/cancers14112784, PubMed 35681766
  3. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
  4. Li RG, Lindland K, Tonstad SK, Bønsdorff TB, Juzeniene A, Westrøm S, Larsen RH (2021)
    Improved Formulation of 224Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP
    Pharmaceutics, 13 (5)
    DOI 10.3390/pharmaceutics13050634, PubMed 33946852
  5. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
  6. Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
    Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
    Clin Epidemiol, 12, 1389-1401
    DOI 10.2147/CLEP.S269446, PubMed 33376408
  7. Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
    Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
    Curr Radiopharm, 14 (2), 145-153
    DOI 10.2174/1874471013666201201102056, PubMed 33261548
  8. Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2020)
    Combinatorial CAR design improves target restriction
    J Biol Chem, 296, 100116
    DOI 10.1074/jbc.RA120.016234, PubMed 33234592
  9. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
  10. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
  11. Grigalavicius M, Mastrangelopoulou M, Arous D, Juzeniene A, Ménard M, Skarpen E, Berg K, Theodossiou TA (2020)
    Photodynamic Efficacy of Cercosporin in 3D Tumor Cell Cultures
    Photochem Photobiol, 96 (3), 699-707
    DOI 10.1111/php.13257, PubMed 32125700
  12. Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
    Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
    Clin Epidemiol, 12, 193-202
    DOI 10.2147/CLEP.S241249, PubMed 32110111
  13. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866
  14. Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE (2019)
    Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study
    BMJ Open, 9 (2), e025246
    DOI 10.1136/bmjopen-2018-025246, PubMed 30787091
  15. Juzeniene A, Bernoulli J, Suominen M, Halleen J, Larsen RH (2018)
    Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model
    Anticancer Res, 38 (4), 1947-1955
    DOI 10.21873/anticanres.12432, PubMed 29599310
  16. Pudroma X, Duoji G, Grigalavicius M, Jie D, Juzeniene A (2017)
    Molecular Mechanisms of UVA-Induced Melanoma
    J Environ Pathol Toxicol Oncol, 36 (3), 217-228
    DOI 10.1615/JEnvironPatholToxicolOncol.2017020213, PubMed 29283335
  17. Gaware VS, Håkerud M, Juzeniene A, Høgset A, Berg K, Másson M (2017)
    Endosome Targeting meso-Tetraphenylchlorin-Chitosan Nanoconjugates for Photochemical Internalization
    Biomacromolecules, 18 (4), 1108-1126
    DOI 10.1021/acs.biomac.6b01670, PubMed 28245649
  18. Grigalavicius M, Juraleviciute M, Kwitniewski M, Juzeniene A (2016)
    The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells
    Photodiagnosis Photodyn Ther, 17, 29-34
    DOI 10.1016/j.pdpdt.2016.10.008, PubMed 27777143
  19. Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB (2016)
    Phototherapy and vitamin D
    Clin Dermatol, 34 (5), 548-55
    DOI 10.1016/j.clindermatol.2016.05.004, PubMed 27638432
  20. Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, Garland CF, Holick MF (2016)
    Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?
    Dermatoendocrinol, 8 (1), e1187349
    DOI 10.1080/19381980.2016.1187349, PubMed 27489574
  21. Grigalavicius M, Iani V, Juzeniene A (2016)
    Layer Thickness of SPF 30 Sunscreen and Formation of Pre-vitamin D
    Anticancer Res, 36 (3), 1409-15
    PubMed 26977044
  22. Juzeniene A, Grigalavicius M, Ma LW, Juraleviciute M (2016)
    Folic acid and its photoproducts, 6-formylpterin and pterin-6-carboxylic acid, as generators of reactive oxygen species in skin cells during UVA exposure
    J Photochem Photobiol B, 155, 116-21
    DOI 10.1016/j.jphotobiol.2016.01.001, PubMed 26780587
  23. Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
    Daily, seasonal, and latitudinal variations in solar ultraviolet A and B radiation in relation to vitamin D production and risk for skin cancer
    Int J Dermatol, 55 (1), e23-8
    DOI 10.1111/ijd.13065, PubMed 26547141
  24. Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MAN (2015)
    Supramolecular nanoscale assemblies for cancer diagnosis and therapy
    J Control Release, 213, 152-167
    DOI 10.1016/j.jconrel.2015.06.034, PubMed 26160308
  25. Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
    Vitamin D and ultraviolet phototherapy in Caucasians
    J Photochem Photobiol B, 147, 69-74
    DOI 10.1016/j.jphotobiol.2015.03.009, PubMed 25846579
  26. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
  27. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
  28. Moan J, Grigalavicius M, Baturaite Z, Dahlback A, Juzeniene A (2014)
    The relationship between UV exposure and incidence of skin cancer
    Photodermatol Photoimmunol Photomed, 31 (1), 26-35
    DOI 10.1111/phpp.12139, PubMed 25213656
  29. Moan J, Grigalavicius M, Dahlback A, Baturaite Z, Juzeniene A (2014)
    Ultraviolet-radiation and health: optimal time for sun exposure
    Adv Exp Med Biol, 810, 423-8
    PubMed 25207380
  30. Juzeniene A, Baturaite Z, Moan J (2014)
    Sun exposure and melanomas on sun-shielded and sun-exposed body areas
    Adv Exp Med Biol, 810, 375-89
    DOI 10.1007/978-1-4939-0437-2_21, PubMed 25207377
  31. Bugaj A, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2006)
    The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac(®)CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study
    Photodiagnosis Photodyn Ther, 3 (1), 27-33
    DOI 10.1016/S1572-1000(05)00109-2, PubMed 25049025
  32. Kaliszewski M, Juzeniene A, Juzenas P, Kwasny M, Kaminski J, Dabrowski Z, Golinski J, Moan J (2005)
    Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid
    Photodiagnosis Photodyn Ther, 2 (2), 129-34
    DOI 10.1016/S1572-1000(05)00012-8, PubMed 25048672
  33. Mikolajewska P, Juzeniene A, Moan J (2007)
    The effect of lidocaine on PpIX photobleaching and outcome of ALA-PDT in vitro
    Photodiagnosis Photodyn Ther, 4 (4), 249-53
    DOI 10.1016/j.pdpdt.2007.10.002, PubMed 25047561
  34. Bugaj A, Kwitniewski M, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2007)
    Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice
    Photodiagnosis Photodyn Ther, 4 (4), 237-41
    DOI 10.1016/j.pdpdt.2007.08.001, PubMed 25047558
  35. Juzeniene A, Moan J (2006)
    The history of PDT in Norway Part II. Recent advances in general PDT and ALA-PDT
    Photodiagnosis Photodyn Ther, 4 (2), 80-7
    DOI 10.1016/j.pdpdt.2006.11.001, PubMed 25047338
  36. Juzeniene A, Moan J (2006)
    The history of PDT in Norway Part one: Identification of basic mechanisms of general PDT
    Photodiagnosis Photodyn Ther, 4 (1), 3-11
    DOI 10.1016/j.pdpdt.2006.11.002, PubMed 25047184
  37. Juzeniene A, Grigalavicius M, Baturaite Z, Moan J (2014)
    Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves
    Int J Hyg Environ Health, 217 (8), 839-44
    DOI 10.1016/j.ijheh.2014.06.002, PubMed 25023193
  38. Moan J, Grigalavicius M, Baturaite Z, Juzeniene A, Dahlback A (2013)
    North-South gradients of melanomas and non-melanomas: A role of vitamin D?
    Dermatoendocrinol, 5 (1), 186-91
    DOI 10.4161/derm.23791, PubMed 24494053
  39. Grigalavicius M, Juzeniene A, Baturaite Z, Dahlback A, Moan J (2013)
    Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma
    Dermatoendocrinol, 5 (1), 150-8
    DOI 10.4161/derm.22941, PubMed 24494048
  40. Juzeniene A, Iani V, Moan J (2013)
    Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid
    Photodiagnosis Photodyn Ther, 10 (4), 538-45
    DOI 10.1016/j.pdpdt.2013.05.008, PubMed 24284108
  41. Moan JE, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
    Sunbed use and cutaneous melanoma in Norway
    Scand J Public Health, 41 (8), 812-7
    DOI 10.1177/1403494813496601, PubMed 23907734
  42. Juzeniene A, Thu Tam TT, Iani V, Moan J (2013)
    The action spectrum for folic acid photodegradation in aqueous solutions
    J Photochem Photobiol B, 126, 11-6
    DOI 10.1016/j.jphotobiol.2013.05.011, PubMed 23892004
  43. Orlova T, Moan J, Lagunova Z, Aksnes L, Terenetskaya I, Juzeniene A (2013)
    Increase in serum 25-hydroxyvitamin-D3 in humans after sunbed exposures compared to previtamin D3 synthesis in vitro
    J Photochem Photobiol B, 122, 32-6
    DOI 10.1016/j.jphotobiol.2013.03.006, PubMed 23591142
  44. Juzeniene A, Nizauskaite Z (2013)
    Photodegradation of cobalamins in aqueous solutions and in human blood
    J Photochem Photobiol B, 122, 7-14
    DOI 10.1016/j.jphotobiol.2013.03.001, PubMed 23558034
  45. Moan J, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
    Cutaneous malignant melanoma incidence rates in Norway
    Scand J Public Health, 41 (4), 336-9
    DOI 10.1177/1403494813479216, PubMed 23439631
  46. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
    Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
    Melanoma Res, 22 (6), 460-5
    DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822
  47. Juzeniene A, Moan J (2012)
    Beneficial effects of UV radiation other than via vitamin D production
    Dermatoendocrinol, 4 (2), 109-17
    DOI 10.4161/derm.20013, PubMed 22928066
  48. Uzdensky A, Kristiansen B, Moan J, Juzeniene A (2012)
    Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study
    Biochim Biophys Acta, 1820 (7), 795-803
    DOI 10.1016/j.bbagen.2012.03.008, PubMed 22484521
  49. Juzeniene A, Grant WB, Moan JE (2012)
    Reply to "Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials"
    Scand J Infect Dis, 44 (9), 712-3
    DOI 10.3109/00365548.2012.658580, PubMed 22385298
  50. Moan J, Nielsen KP, Juzeniene A (2011)
    Immediate pigment darkening: its evolutionary roles may include protection against folate photosensitization
    FASEB J, 26 (3), 971-5
    DOI 10.1096/fj.11-195859, PubMed 22159146
  51. Pudroma X, Juzeniene A, Ma LW, Iani V, Moan J (2011)
    Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes
    J Environ Pathol Toxicol Oncol, 30 (3), 235-40
    DOI 10.1615/jenvironpatholtoxicoloncol.v30.i3.60, PubMed 22126616
  52. Mikolajewska P, Rømoen OT, Martinsen OG, Iani V, Moan J, Grimnes S, Juzeniene A (2011)
    Bioimpedance for pain monitoring during cutaneous photodynamic therapy: Preliminary study
    Photodiagnosis Photodyn Ther, 8 (4), 307-13
    DOI 10.1016/j.pdpdt.2011.06.001, PubMed 22122917
  53. Moan J, Baturaite Z, Juzeniene A, Porojnicu AC (2011)
    Vitamin D, sun, sunbeds and health
    Public Health Nutr, 15 (4), 711-5
    DOI 10.1017/S1368980011002801, PubMed 22017922
  54. Micu E, Juzeniene A, Moan J (2011)
    Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway
    J Eur Acad Dermatol Venereol, 25 (12), 1444-9
    DOI 10.1111/j.1468-3083.2011.04023.x, PubMed 21995584
  55. Moan J, Baturaite Z, Porojnicu AC, Dahlback A, Juzeniene A (2011)
    UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden
    Photochem Photobiol Sci, 11 (1), 191-8
    DOI 10.1039/c1pp05215b, PubMed 21986949
  56. Juzeniene A, Micu E, Porojnicu AC, Moan J (2011)
    Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway
    J Eur Acad Dermatol Venereol, 26 (7), 821-7
    DOI 10.1111/j.1468-3083.2011.04162.x, PubMed 21707773
  57. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011)
    Photodynamic therapy of cancer: an update
    CA Cancer J Clin, 61 (4), 250-81
    DOI 10.3322/caac.20114, PubMed 21617154
  58. Moan J, Dahlback A, Ma L, Juzeniene A (2009)
    Influenza, solar radiation and vitamin D
    Dermatoendocrinol, 1 (6), 307-9
    DOI 10.4161/derm.1.6.11357, PubMed 21572876
  59. Moan J, Cicarma E, Setlow R, Porojnicu AC, Grant WB, Juzeniene A (2010)
    Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation
    Dermatoendocrinol, 2 (1), 3-8
    DOI 10.4161/derm.2.1.11745, PubMed 21547141
  60. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
    Seasonal variations of cancer incidence and prognosis
    Dermatoendocrinol, 2 (2), 55-7
    DOI 10.4161/derm.2.2.12664, PubMed 21547098
  61. Juzeniene A, Moan J (2011)
    [UV-A radiation and melanomas]
    Tidsskr Nor Laegeforen, 131 (4), 333; author reply 333-4
    DOI 10.4045/tidsskr.10.1124, PubMed 21339772
  62. Juzeniene A, Juzenas P, Iani V, Moan J (2010)
    Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate
    Photodiagnosis Photodyn Ther, 7 (4), 239-45
    DOI 10.1016/j.pdpdt.2010.07.001, PubMed 21112546
  63. Juzeniene A, Ma LW, Kwitniewski M, Polev GA, Lagunova Z, Dahlback A, Moan J (2010)
    The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D
    Int J Infect Dis, 14 (12), e1099-105
    DOI 10.1016/j.ijid.2010.09.002, PubMed 21036090
  64. Kwitniewski M, Moan J, Juzeniene A (2010)
    Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy
    Photochem Photobiol Sci, 10 (1), 25-8
    DOI 10.1039/c0pp00193g, PubMed 20978658
  65. Moan J, Juzeniene A (2010)
    Solar radiation and human health
    J Photochem Photobiol B, 101 (2), 109-10
    DOI 10.1016/j.jphotobiol.2010.08.004, PubMed 20833325
  66. Grant WB, Juzeniene A, Moan JE (2010)
    Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries
    Scand J Public Health, 39 (1), 70-8
    DOI 10.1177/1403494810382473, PubMed 20817654
  67. Juzenas P, Juzeniene A (2010)
    Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors
    Photodiagnosis Photodyn Ther, 7 (3), 152-7
    DOI 10.1016/j.pdpdt.2010.06.003, PubMed 20728838
  68. Grant WB, Moan JE, Micu E, Porojnicu AC, Juzeniene A (2010)
    Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers
    Fam Cancer, 9 (4), 659-60; discussion 661-2
    DOI 10.1007/s10689-010-9374-1, PubMed 20711817
  69. Mikolajewska P, Donnelly RF, Garland MJ, Morrow DI, Singh TR, Iani V, Moan J, Juzeniene A (2010)
    Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema
    Pharm Res, 27 (10), 2213-20
    DOI 10.1007/s11095-010-0227-2, PubMed 20676735
  70. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches
    J Pharm Pharmacol, 62 (6), 685-95
    DOI 10.1211/jpp.62.06.0004, PubMed 20636855
  71. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Novel patch-based systems for the localised delivery of ALA-esters
    J Photochem Photobiol B, 101 (1), 59-69
    DOI 10.1016/j.jphotobiol.2010.06.012, PubMed 20634088
  72. Grant WB, Juzeniene A, Lagunova Z, Porojnicu AC, Moan JE (2011)
    Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer
    Int J Cancer, 128 (9), 2249-50
    DOI 10.1002/ijc.25552, PubMed 20626044
  73. Juzeniene A, Juzenas P, Moan J (2010)
    Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo
    Methods Mol Biol, 635, 97-106
    DOI 10.1007/978-1-60761-697-9_7, PubMed 20552342
  74. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
    Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
    J Photochem Photobiol B, 101 (2), 174-8
    DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639
  75. Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A (2010)
    Where the sun does not shine: is sunshine protective against melanoma of the vulva?
    J Photochem Photobiol B, 101 (2), 179-83
    DOI 10.1016/j.jphotobiol.2010.03.003, PubMed 20359907
  76. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses
    J Pharm Sci, 99 (8), 3486-98
    DOI 10.1002/jps.22116, PubMed 20222026
  77. Juzeniene A, Stokke KT, Thune P, Moan J (2010)
    Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure
    J Photochem Photobiol B, 101 (2), 111-6
    DOI 10.1016/j.jphotobiol.2010.01.013, PubMed 20207157
  78. Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J (2010)
    Influence of narrowband UVB phototherapy on vitamin D and folate status
    Exp Dermatol, 19 (8), e67-72
    DOI 10.1111/j.1600-0625.2009.00987.x, PubMed 19849714
  79. Juzeniene A, Moan J (2009)
    [Sun, vitamin D and health]
    Tidsskr Nor Laegeforen, 129 (19), 2019
    DOI 10.4045/tidsskr.09.0444, PubMed 19823211
  80. Mikolajewska P, Iani V, Juzeniene A, Moan J (2009)
    Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema
    Br J Dermatol, 161 (5), 1173-9
    DOI 10.1111/j.1365-2133.2009.09437.x, PubMed 19785604
  81. Juzeniene A (2009)
    Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis
    Photodiagnosis Photodyn Ther, 6 (2), 94-6
    DOI 10.1016/j.pdpdt.2009.06.001, PubMed 19683209
  82. Cicarma E, Porojnicu AC, Lagunova Z, Dahlback A, Juzeniene A, Moan J (2009)
    Sun and sun beds: inducers of vitamin D and skin cancer
    Anticancer Res, 29 (9), 3495-500
    PubMed 19667143
  83. Juzeniene A, Thu Tam TT, Iani V, Moan J (2009)
    5-Methyltetrahydrofolate can be photodegraded by endogenous photosensitizers
    Free Radic Biol Med, 47 (8), 1199-204
    DOI 10.1016/j.freeradbiomed.2009.07.030, PubMed 19647791
  84. Kwitniewski M, Jankowski D, Jaskiewicz K, Dziadziuszko H, Juzeniene A, Moan J, Ma LW, Peksa R, Kunikowska D, Graczyk A, Kwasny M, Kaliszewski M, Glosnicka R (2009)
    Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin
    Int J Cancer, 125 (7), 1721-7
    DOI 10.1002/ijc.24488, PubMed 19521986
  85. Juzeniene A, Setlow R, Porojnicu A, Steindal AH, Moan J (2009)
    Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects
    J Photochem Photobiol B, 96 (2), 93-100
    DOI 10.1016/j.jphotobiol.2009.04.009, PubMed 19481954
  86. Pudroma X, Moan J, Ma LW, Iani V, Juzeniene A (2009)
    A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin
    Exp Dermatol, 18 (11), 985-7
    DOI 10.1111/j.1600-0625.2009.00863.x, PubMed 19469901
  87. Cicarma E, Tuorkey M, Juzeniene A, Ma LW, Moan J (2009)
    Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells
    Br J Dermatol, 161 (2), 413-8
    DOI 10.1111/j.1365-2133.2009.09180.x, PubMed 19438460
  88. Juzeniene A, Nielsen KP, Zhao L, Ryzhikov GA, Biryulina MS, Stamnes JJ, Stamnes K, Moan J (2008)
    Changes in human skin after topical PDT with hexyl aminolevulinate
    Photodiagnosis Photodyn Ther, 5 (3), 176-81
    DOI 10.1016/j.pdpdt.2008.07.001, PubMed 19356652
  89. Donnelly RF, McCarron PA, Al-Kassas R, Juzeniene A, Juzenas P, Iani V, Woolfson AD, Moan J (2009)
    Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles
    Biopharm Drug Dispos, 30 (2), 55-70
    DOI 10.1002/bdd.645, PubMed 19226650
  90. Wold JP, Veberg Dahl A, Lundby F, Nilsen AN, Juzeniene A, Moan J (2008)
    Effect of oxygen concentration on photo-oxidation and photosensitizer bleaching in butter
    Photochem Photobiol, 85 (3), 669-76
    DOI 10.1111/j.1751-1097.2008.00492.x, PubMed 19140897
  91. Juzenas P, Juzeniene A, Iani V, Moan J (2008)
    Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model
    Photochem Photobiol, 85 (3), 760-4
    DOI 10.1111/j.1751-1097.2008.00496.x, PubMed 19140894
  92. Tam TT, Juzeniene A, Steindal AH, Iani V, Moan J (2008)
    Photodegradation of 5-methyltetrahydrofolate in the presence of Uroporphyrin
    J Photochem Photobiol B, 94 (3), 201-4
    DOI 10.1016/j.jphotobiol.2008.12.003, PubMed 19138530
  93. Kwitniewski M, Juzeniene A, Ma LW, Glosnicka R, Graczyk A, Moan J (2008)
    Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies
    J Photochem Photobiol B, 94 (3), 214-22
    DOI 10.1016/j.jphotobiol.2008.11.005, PubMed 19136276
  94. Mikolajewska P, Juzeniene A, Moan J (2008)
    Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy
    Transl Res, 152 (3), 128-33
    DOI 10.1016/j.trsl.2008.07.004, PubMed 18774542
  95. Donnelly RF, Morrow DI, McCarron PA, David Woolfson A, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer
    Photochem Photobiol, 85 (1), 195-204
    DOI 10.1111/j.1751-1097.2008.00417.x, PubMed 18764907
  96. Kwitniewski M, Juzeniene A, Glosnicka R, Moan J (2008)
    Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?
    Photochem Photobiol Sci, 7 (9), 1011-7
    DOI 10.1039/b806710d, PubMed 18754046
  97. Steindal AH, Tam TT, Lu XY, Juzeniene A, Moan J (2008)
    5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin
    Photochem Photobiol Sci, 7 (7), 814-8
    DOI 10.1039/b718907a, PubMed 18597029
  98. Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy
    J Control Release, 129 (3), 154-62
    DOI 10.1016/j.jconrel.2008.05.002, PubMed 18556084
  99. Juzeniene A, Juzenas P, Iani V, Moan J (2007)
    Topical applications of iron chelators in photosensitization
    Photochem Photobiol Sci, 6 (12), 1268-74
    DOI 10.1039/b703861e, PubMed 18046481
  100. Juzeniene A, Peng Q, Moan J (2007)
    Milestones in the development of photodynamic therapy and fluorescence diagnosis
    Photochem Photobiol Sci, 6 (12), 1234-45
    DOI 10.1039/b705461k, PubMed 18046478
  101. Kaliszewski M, Kwasny M, Juzeniene A, Juzenas P, Graczyk A, Ma LW, Iani V, Mikolajewska P, Moan J (2007)
    Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions
    J Photochem Photobiol B, 87 (2), 67-72
    DOI 10.1016/j.jphotobiol.2007.01.003, PubMed 17350278
  102. Gonzalez H, Tarras-Wahlberg N, Strömdahl B, Juzeniene A, Moan J, Larkö O, Rosén A, Wennberg AM (2007)
    Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps
    BMC Dermatol, 7, 1
    DOI 10.1186/1471-5945-7-1, PubMed 17324264
  103. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2006)
    Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
    Br J Dermatol, 155 (4), 791-9
    DOI 10.1111/j.1365-2133.2006.07484.x, PubMed 16965430
  104. Ma L, Steindal AE, Juzeniene A, Iani V, Moan J (2006)
    The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate
    Photochem Photobiol Sci, 5 (8), 755-9
    DOI 10.1039/b603828j, PubMed 16886091
  105. Steindal AH, Juzeniene A, Johnsson A, Moan J (2006)
    Photodegradation of 5-methyltetrahydrofolate: biophysical aspects
    Photochem Photobiol, 82 (6), 1651-5
    DOI 10.1562/2006-06-09-RA-915, PubMed 16879038
  106. Bronshteint I, Aulova S, Juzeniene A, Iani V, Ma LW, Smith KM, Malik Z, Moan J, Ehrenberg B (2006)
    In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane
    Photochem Photobiol, 82 (5), 1319-25
    DOI 10.1562/2006-04-02-RA-865, PubMed 16740058
  107. Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J (2006)
    The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
    J Photochem Photobiol B, 84 (2), 161-6
    DOI 10.1016/j.jphotobiol.2006.02.009, PubMed 16624569
  108. Zhao L, Nielsen KP, Juzeniene A, Juzenas P, Lani V, Ma LW, Stamnes K, Stamnes JJ, Moan J (2006)
    Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid
    J Environ Pathol Toxicol Oncol, 25 (1-2), 307-20
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.200, PubMed 16566726
  109. Juzeniene A, Nielsen KP, Moan J (2006)
    Biophysical aspects of photodynamic therapy
    J Environ Pathol Toxicol Oncol, 25 (1-2), 7-28
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.20, PubMed 16566708
  110. Juzenas P, Juzeniene A, Iani V, Moan J (2006)
    The influence of light and darkness on cutaneous fluorescence in mice
    Luminescence, 21 (3), 159-63
    DOI 10.1002/bio.900, PubMed 16502394
  111. Bugaj A, Juzeniene A, Juzenas P, Iani V, Ma LW, Moan J (2006)
    The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid
    J Photochem Photobiol B, 83 (2), 94-7
    DOI 10.1016/j.jphotobiol.2005.12.003, PubMed 16442808
  112. Moan J, Ma L, Iani V, Juzeniene A (2005)
    Influence of light exposure on the kinetics of protoporphyrin IX formation in normal skin of hairless mice after application of 5-aminolevulinic acid methyl ester
    J Invest Dermatol, 125 (5), 1039-44
    DOI 10.1111/j.0022-202X.2005.23863.x, PubMed 16297207
  113. Off MK, Steindal AE, Porojnicu AC, Juzeniene A, Vorobey A, Johnsson A, Moan J (2005)
    Ultraviolet photodegradation of folic acid
    J Photochem Photobiol B, 80 (1), 47-55
    DOI 10.1016/j.jphotobiol.2005.03.001, PubMed 15963436
  114. Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ, Moan J (2005)
    Choice of optimal wavelength for PDT: the significance of oxygen depletion
    Photochem Photobiol, 81 (5), 1190-4
    DOI 10.1562/2005-04-06-RA-478, PubMed 15934793
  115. Juzenas P, Juzeniene A, Moan J (2005)
    Deferoxamine photosensitizes cancer cells in vitro
    Biochem Biophys Res Commun, 332 (2), 388-91
    DOI 10.1016/j.bbrc.2005.04.138, PubMed 15910749
  116. Uzdensky A, Kolpakova E, Juzeniene A, Juzenas P, Moan J (2004)
    The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells
    Biochim Biophys Acta, 1722 (1), 43-50
    DOI 10.1016/j.bbagen.2004.11.011, PubMed 15716135
  117. Moan J, Porojnicu AC, Robsahm TE, Dahlback A, Juzeniene A, Tretli S, Grant W (2005)
    Solar radiation, vitamin D and survival rate of colon cancer in Norway
    J Photochem Photobiol B, 78 (3), 189-93
    DOI 10.1016/j.jphotobiol.2004.11.004, PubMed 15708515
  118. Lassalle HP, Bezdetnaya L, Iani V, Juzeniene A, Guillemin F, Moan J (2004)
    Photodegradation and phototransformation of 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC) in solution
    Photochem Photobiol Sci, 3 (11-12), 999-1005
    DOI 10.1039/b405138f, PubMed 15570386
  119. Kaestner L, Juzeniene A, Moan J (2004)
    Erythrocytes-the 'house elves' of photodynamic therapy
    Photochem Photobiol Sci, 3 (11-12), 981-9
    DOI 10.1039/b403127j, PubMed 15570383
  120. Kristiansson S, Juzeniene A, Juzenas P, Iani V, Löfgren L, Moan J (2005)
    Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester
    Photochem Photobiol, 81 (2), 394-7
    DOI 10.1562/2004-04-02-RA-132, PubMed 15535733
  121. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004)
    Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
    Lasers Med Sci, 19 (3), 139-49
    DOI 10.1007/s10103-004-0314-x, PubMed 15503248
  122. Uzdensky AB, Juzeniene A, Kolpakova E, Hjortland GO, Juzenas P, Moan J (2004)
    Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum
    Biochem Biophys Res Commun, 322 (2), 452-7
    DOI 10.1016/j.bbrc.2004.07.132, PubMed 15325251
  123. Juzenas P, Juzeniene A, Rotomskis R, Moan J (2004)
    Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions
    J Photochem Photobiol B, 75 (1-2), 107-10
    DOI 10.1016/j.jphotobiol.2004.05.011, PubMed 15246357
  124. Collaud S, Juzeniene A, Moan J, Lange N (2004)
    On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation
    Curr Med Chem Anticancer Agents, 4 (3), 301-16
    DOI 10.2174/1568011043352984, PubMed 15134506
  125. Uzdensky A, Juzeniene A, Ma LW, Moan J (2004)
    Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum
    Biochim Biophys Acta, 1670 (1), 1-11
    DOI 10.1016/j.bbagen.2003.10.013, PubMed 14729136
  126. Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002)
    Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo
    Cell Mol Biol (Noisy-le-grand), 48 (8), 911-6
    PubMed 12699250
  127. Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J (2002)
    Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo
    Photochem Photobiol Sci, 1 (10), 745-8
    DOI 10.1039/b203459j, PubMed 12656473
  128. Moan J, Ma LW, Juzeniene A, Iani V, Juzenas P, Apricena F, Peng Q (2003)
    Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
    Int J Cancer, 103 (1), 132-5
    DOI 10.1002/ijc.10802, PubMed 12455066
  129. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002)
    Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin
    Photochem Photobiol, 76 (4), 452-6
    DOI 10.1562/0031-8655(2002)076<0452:teoaop>2.0.co;2, PubMed 12405155
  130. Juzeniene A, Juzenas P, Iani V, Moan J (2002)
    Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model
    Photochem Photobiol, 76 (3), 329-34
    DOI 10.1562/0031-8655(2002)076<0329:taoaaa>2.0.co;2, PubMed 12403455
  131. Juzenas P, Juzeniene A, Stakland S, Iani V, Moan J (2002)
    Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice
    Biochem Biophys Res Commun, 297 (3), 468-72
    DOI 10.1016/s0006-291x(02)02238-6, PubMed 12270116
  132. Juzenas P, Generalov R, Juzeniene A, Moan J (2008)
    Generation of Nitrogen Oxide and Oxygen Radicals by Quantum Dots
    J. Biomed. Nanotechnol., 4 (4), 450-456
    DOI 10.1166/jbn.2008.008
  133. Mikolajewska P, Juzeniene A, Iani V, Sollund H, Norsang G, Moan J (2009)
    A pilot study comparing the pain sensations during PpIX build-up and clearance phases
    PROC SPIE, 7380, 73802Y
    DOI 10.1117/12.822949
  134. Generalov R, Lukoseviciute S, Juzeniene A, Juzenas P (2010)
    Cytotoxicity and Phototoxicity of Red Fluorescent Nontargeted Quantum Dots
    IEEE J. Sel. Top. Quantum Electron., 16 (4), 997-1003
    DOI 10.1109/JSTQE.2009.2034387
  135. Juzeniene A, Brekke P, Dahlback A, Andersson-Engels S, Reichrath J, Moan K, Holick MF, Grant WB, Moan J (2011)
    Solar radiation and human health
    Rep. Prog. Phys., 74 (6), 066701
    DOI 10.1088/0034-4885/74/6/066701
  136. Peng Q, Juzeniene A, Chen J, Svaasand LO, Warloe T, Giercksky KE, Moan J (2008)
    Lasers in medicine
    Rep. Prog. Phys., 71 (5), 056701
    DOI 10.1088/0034-4885/71/5/056701
  137. Juzeniene A, Kaliszewski M, Bugaj A, Moan J (2009)
    Clearance of protoporphyrin IX induced by 5-aminolevulinic acid from WiDr human colon carcinoma cells
    PROC SPIE, 7380, 73802Q
    DOI 10.1117/12.822944

 
Page visits: 2456